Thermal stability and kinetic constants for 129 variants of a family 1 glycoside hydrolase reveal that enzyme activity and stability can be separately designed

PloS One
Dylan Alexander CarlinJustin B Siegel

Abstract

Accurate modeling of enzyme activity and stability is an important goal of the protein engineering community. However, studies seeking to evaluate current progress are limited by small data sets of quantitative kinetic constants and thermal stability measurements. Here, we report quantitative measurements of soluble protein expression in E. coli, thermal stability, and Michaelis-Menten constants (kcat, KM, and kcat/KM) for 129 designed mutants of a glycoside hydrolase. Statistical analyses reveal that functional Tm is independent of kcat, KM, and kcat/KM in this system, illustrating that an individual mutation can modulate these functional parameters independently. In addition, this data set is used to evaluate computational predictions of protein stability using the established Rosetta and FoldX algorithms. Predictions for both are found to correlate only weakly with experimental measurements, suggesting improvements are needed in the underlying algorithms.

References

Jun 5, 1992·Journal of Molecular Biology·E M MeieringA R Fersht
Jan 17, 1995·Proceedings of the National Academy of Sciences of the United States of America·B K ShoichetB W Matthews
Jun 7, 2002·IUBMB Life·Thomas K Harris, George J Turner
Jun 25, 2002·Journal of Molecular Biology·Raphael GueroisLuis Serrano
Jul 30, 2002·Journal of Molecular Biology·Beth M Beadle, Brian K Shoichet
Jun 28, 2005·Nucleic Acids Research·Joost SchymkowitzLuis Serrano
Dec 31, 2005·Nucleic Acids Research·M D Shaji KumarAkinori Sarai
Apr 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jesse D BloomFrances H Arnold
Mar 21, 2008·Nature·Daniela RöthlisbergerDavid Baker
May 9, 2008·PLoS Computational Biology·Nobuhiko TokurikiDan S Tawfik
Jun 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jesse D Bloom, Frances H Arnold
Nov 17, 2009·Journal of Molecular Biology·Veena L ThomasBrian K Shoichet
Nov 26, 2009·Nature Reviews. Molecular Cell Biology·Philip A Romero, Frances H Arnold
Jul 17, 2010·Nature Reviews. Genetics·Misha Soskine, Dan S Tawfik
May 24, 2011·PloS One·Florian RichterDavid Baker
Feb 21, 2013·Methods in Enzymology·Andrew Leaver-FayBrian Kuhlman
Jun 4, 2015·Proceedings of the National Academy of Sciences of the United States of America·Philip A RomeroAdam R Abate
Sep 17, 2015·Journal of the American Chemical Society·Clancey WolfIngrid S Pultz
Mar 10, 2016·Nature Communications·Jan-Ytzen van der MeerGerrit J Poelarends
Nov 26, 2016·Current Opinion in Structural Biology·Emily E WrenbeckTimothy A Whitehead

❮ Previous
Next ❯

Citations

Jul 3, 2021·Frontiers in Bioengineering and Biotechnology·Marc SchererElena Bencurova

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
PCR
protein folding

Software Mentioned

Foldit
SciPy
PyMOL
Rosetta ddg _ monomer
RosettaDesign
Rosetta
PSSM
FoldX

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.